AKT1 and hepatocellular carcinoma: Thus, downregulation of miR-375 leads to AEG-1 overexpression, which activates the PI3K/Akt, NF-κB, and Wnt/β-catenin signaling pathways, reversing the antitumor effects of miR-375 deprivation in HCC [168,169].